Intensified concomitant chemoradiotherapy for poor-prognosis head and neck cancer

Comment

I Alastuey. J Clin Oncol. 1995 May.

. 1995 May;13(5):1281-2.

doi: 10.1200/JCO.1995.13.5.1281.

No abstract available

Comment on

Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer.
Vokes EE, Haraf DJ, Mick R, McEvilly JM, Weichselbaum RR. Vokes EE, et al. J Clin Oncol. 1994 Nov;12(11):2351-9. doi: 10.1200/JCO.1994.12.11.2351. J Clin Oncol. 1994. PMID: 7525886 Clinical Trial.

[Head and neck: concurrent chemoradiotherapy].
Higaki Y, Tomita Y. Higaki Y, et al. Gan To Kagaku Ryoho. 2007 Jul;34(7):1031-3. Gan To Kagaku Ryoho. 2007. PMID: 17682303 Japanese. No abstract available.
The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer.
Vokes EE, Haraf DJ, Kies MS. Vokes EE, et al. Semin Oncol. 2000 Aug;27(4 Suppl 8):34-8. Semin Oncol. 2000. PMID: 10952436 Review.
Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer.
Vokes EE, Haraf DJ, Mick R, McEvilly JM, Weichselbaum RR. Vokes EE, et al. J Clin Oncol. 1994 Nov;12(11):2351-9. doi: 10.1200/JCO.1994.12.11.2351. J Clin Oncol. 1994. PMID: 7525886 Clinical Trial.
Head and neck cancer.
Taylor SG 4th. Taylor SG 4th. Cancer Chemother Biol Response Modif. 2001;19:465-83. Cancer Chemother Biol Response Modif. 2001. PMID: 11686028 Review. No abstract available.
Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer With hyperfractionated radiation and concurrent chemotherapy.
Adelstein DJ, Saxton JP, Lavertu P, Rybicki LA, Esclamado RM, Wood BG, Strome M, Carroll MA. Adelstein DJ, et al. J Clin Oncol. 2002 Mar 1;20(5):1405-10. doi: 10.1200/JCO.2002.20.5.1405. J Clin Oncol. 2002. PMID: 11870186